Biophysical properties of the clinical-stage antibody landscape

[rbharath]

http://www.pnas.org/content/114/5/944.full

Contains a large (by standards of field :-)) dataset of all antibodies tested in phase-2 or phase-3 clinical trials measured "criteria regarding the feasibility of their manufacture, stability in storage, and absence of off-target stickiness."

This could be a valuable dataset for benchmarking antibody algorithmic techniques.